Medi Assist Healthcare Services Limited has scheduled its 26th Annual General Meeting (AGM) for Thursday, September 24, 2026. The meeting will be conducted through Video Conference or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs and SEBI regulations.

The Board of Directors has recommended a final dividend of ₹2 per equity share of face value ₹5 each for the financial year ended March 31, 2026 (FY26). This recommendation is subject to shareholder approval at the AGM. The record date for determining eligibility for the final dividend is Friday, September 11, 2026. If approved, the dividend will be paid within 30 days of the shareholders' approval.

Meeting Logistics

Participants can access the meeting via a dedicated video conferencing link using remote e-voting credentials. Shareholders holding shares as of the cut-off date, Thursday, September 17, 2026, are eligible to vote electronically. The remote e-voting period commences on Monday, September 21, 2026, at 9:00 am and ends on Wednesday, September 23, 2026, at 5:00 pm.

Shareholders without registered emails will receive a letter containing a web-link and QR code to access the documents on the company website. Results of the e-voting will be published within two working days of the meeting. M/s. BMP & Co. LLP has been appointed as the Scrutinizer to oversee the e-voting process.

Medi Assist Healthcare Services Limited reported a consolidated net profit of ₹276 million (₹27.6 Cr) for Q1FY27, marking a 21.9% year-on-year increase from ₹226.31 million in the prior period. Total income rose 24.9% to ₹2,470 million (₹247.0 Cr), driven by a 24.1% expansion in operating revenue to ₹2,365.19 million. The company declared that its Paramount Healthcare Services acquisition integration is at its "logical closure," signaling a transition from consolidation costs to operational leverage. Despite top-line growth, consolidated EBITDA margin contracted by 175 basis points to 20.3%, down from 22.0% in Q1FY26, as the firm balances integration expenses with new technology investments.

The Board of Directors approved the unaudited results on August 8, 2026, and filed the press release on August 9, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Standalone net profit after tax surged 64% to ₹131.52 million, significantly outpacing consolidated growth, indicating strong operational efficiency at the parent entity level. Adjusted PAT, excluding a one-time ₹3.1 Cr derivative gain from the Mayfair acquisition, grew 8.2% to ₹245 million (₹24.5 Cr).

Segment Performance and Market Share

The Group business remained the primary revenue driver, contributing 70.2% of total revenue with a 25.5% year-on-year growth to ₹166.0 Cr. Premiums managed in the Group segment grew 29.5% to ₹8,454 Cr, expanding market share by 440 basis points to 37.6%. Fraud savings in this segment jumped 46.7% to approximately ₹151 Cr. In contrast, Retail TPA revenue grew 13.1% to ₹23.4 Cr, though premiums managed declined 5.0% to ₹521 Cr as the business shifts to a hybrid model. The Government segment saw robust 35.3% revenue growth to ₹28.5 Cr, servicing approximately 31 crore members across 12 states and 4 Union Territories.

Technology Monetization and International Expansion

Technology revenues emerged as a high-growth vector, rising 55.5% year-on-year to ₹7.8 Cr and accounting for 3.3% of total revenue. Medi Assist completed its planned ~₹24.5 Cr AI platform investment over the last six quarters. The stack — including MAven IDP, MAven Guard, and MATrix — is now generally available, with seven insurers contracted for AI services, including its first gain-share model. Internationally, Medi Assist raised its stake in Mayfair We Care to 91.75%, appointing Nikhil Chopra to lead the international business. The MAven platform was deployed in Thailand effective July 1, 2026. However, international benefits administration revenue softened by 5.2% to ₹10.1 Cr due to a >20% decline in leisure travelers and a >35% drop in students going abroad.

What the Numbers Show

The divergence between standalone and consolidated profitability highlights the transitional nature of the Paramount integration. While standalone net profit grew 64%, consolidated profit grew only 22%, suggesting that subsidiary operations are currently absorbing integration costs or facing margin pressure. The EBITDA margin recovery trajectory—rising from a trough of 17.1% in Q2FY26 to 20.3% in Q1FY27—indicates that integration efficiencies are beginning to materialize, though full normalization is expected by Q2FY27 when 100% claims volume migration is targeted. The debt-free balance sheet with a free cash position of ₹245.5 Cr provides ample runway for these investments without dilution. Governance changes include Dr. Vikram Jit Singh Chhatwal transitioning to Non-Executive Chairman and Gaurav Bhatnagar joining as Chief TPA Officer.